Skip to content
Antibodies & Bispecifics
Antibody Platforms
Monoclonal Discovery
Bispecific Discovery
Optimization
TCR Mimics
Genetic Medicines
Partnering
Ecosystem Allies
About
Leadership
News and Events
Careers
Resources
Antibodies & Bispecifics
Antibody Platforms
Monoclonal Discovery
Bispecific Discovery
Optimization
TCR Mimics
Genetic Medicines
Partnering
Ecosystem Allies
About
Leadership
News and Events
Careers
Resources
Contact Us
Full resource library
Alloy Therapeutics resources all in one place
Modality
Solution
Type
Modality
Antibodies and Bispecifics
Genetic Medicines
TCR Mimics
Solution
Antibody Platforms
Bispecific Discovery
Monoclonal Discovery
Optimization
TCR Mimic
Type
Case Studies
Perspectives
Press Releases
Technical Notes
Webinars
Webinars
Daedamab High Velocity Antibody Discovery
Learn more
Press Releases
Alloy Therapeutics Announces New Licensing Model for ATX-Gx™ Antibody Discovery Platform and Launches mAbForge™ High-Throughput Screening Service
Learn more
Press Releases
Alloy Therapeutics Announces a Target Specific Collaboration and License Agreement for use of AntiClastic™ Antisense Platform with Sanofi
Learn more
Webinars
Keyway TCRm Discovery Webinar
Learn more
Webinars
Discovering Antibodies in Months
Learn more
Technical Notes
Approaches to Binder Recovery Following Immunization Campaigns in Mouse Models
Learn more
Technical Notes
Harnessing the Potential of Human Lambda Light Chains in Antibody Discovery Campaigns
Learn more
Technical Notes
Targeting GPCRs With DeepImmune™
Learn more
Webinars
AET US 2023: Tackling Tough Targets in Antibody Discovery by Leveraging a Diverse Suite of In Vivo Discovery Platforms
Learn more
